Narrow search
Showing 1 - 10 of 72,284
Cover Image
Excess prices for drugs in medicare : diagnosis and prescription
Frank, Richard G.; Zeckhauser, Richard - 2018
Persistent link: https://www.econbiz.de/10011815118
Cover Image
The price elasticity of specialty drug use : evidence from cancer patients in medicare part D
Jung, Jeah; Feldman, Roger D.; McBean, A. Marshall - In: Forum for health economics & policy : an evolving … 20 (2017) 2, pp. 1-19
Persistent link: https://www.econbiz.de/10011817397
Cover Image
The impact of the 340B Drug Pricing Program on Critical Access Hospitals : evidence from Medicare Part B
Han, Dan - In: Journal of health economics 89 (2023), pp. 1-30
Persistent link: https://www.econbiz.de/10014315980
Cover Image
Frequency connectedness and cross-quantile dependence among medicare, medicine prices and health-tech equity
Kazi Sohag; Shams, S. M. Riad; Gainetdinova, Anna; … - In: Technovation : the international journal of … 120 (2023), pp. 1-16
Persistent link: https://www.econbiz.de/10014476572
Cover Image
Impact of price control on pharmaceutical sector with reference to India
Kolte, Ashutosh; Mal, Hoshiar; Fulambrikar, Mugdha; … - In: International journal of intelligent enterprise 8 (2021) 1, pp. 90-104
Persistent link: https://www.econbiz.de/10012512495
Cover Image
Public drug insurance and children's use of mental health medication : risk-specific responses to lower out-of-pocket treatment costs
Furzer, Jill; Isabelle, Maripier; Miloucheva, Boriana; … - 2021
Persistent link: https://www.econbiz.de/10012624667
Cover Image
Pricing the pharmaceuticals when the ability to pay differs
Kanniainen, Vesa; Laine, Juha; Linnosmaa, Ismo - In: Journal of the Finnish Economic Association : JFEA 2 (2021) 1, pp. 25-48
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. This paper analyses the public insurance of a patent-protected pharmaceutical product in terms of price controls and socially optimal third-degree price discrimination. First, the paper...
Persistent link: https://www.econbiz.de/10013286496
Cover Image
Pricing the pharmaceuticals when the ability to pay differs : taking vertical equity seriously
Kanniainen, Vesa; Laine, Juha; Linnosmaa, Ismo - 2019
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...
Persistent link: https://www.econbiz.de/10012157261
Cover Image
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron; Zhang, Yuting - In: Health economics 23 (2014) 11, pp. 1287-1300
Persistent link: https://www.econbiz.de/10011308176
Cover Image
Anticipatory behavior in response to Medicare Part D's coverage gap
Kaplan, Cameron M.; Zhang, Yuting - In: Health economics 26 (2017) 3, pp. 338-351
Persistent link: https://www.econbiz.de/10011815376